中新网北京9月24日电(记者 欧阳开宇)中国卫生部长陈竺24日晚在北京表示，积极鼓励各类跨国制药企业和相关研究机构在华设立研发中心，并将研发成果实现本地转化。

Beijing on September 24, Beijing(Reporter OuYangKaiYu)China's health minister Outlines 24 late said in Beijing,Actively encourage all kinds of multinational pharmaceutical enterprises and related research institutes establishing r&d centers in China,And the research achievements to realize local transformation.

　　陈竺当天在北京举行的诺和诺德中国研发中心揭牌仪式上说，中国已将建设创新型国家设定为今后的战略目标之一，这将给医药研发产业带来强大的动力。我们欢迎具有成熟的科研管理水平的国际机构与中国医学界展开科研合作。

Outlines the day held in Beijing novo nordisk China r&d center was inaugurated says,China has will be building the innovative country setting for future strategic goal of,This will give medicine research and development industry with a strong power.We welcome have mature scientific research management level of international institutions and Chinese medicine spread scientific research cooperation.

　　陈竺说，随着工业化、城镇化、老龄化进程加快，慢性病患病、死亡呈现持续、快速增长趋势，对民众带来巨大的威胁和挑战，慢性病已成为影响中国居民健康水平提高、阻碍经济社会发展的重大公共卫生问题和社会问题。慢性病的防治需要综合措施，更需要社会各界、各国的共同参与和努力。

Outlines said,Along with the industrialization/urbanization/To speed up the aging process,Chronic illnesses/Death present continuous/Rapid growth trend,People to bring huge threats and challenges,Chronic disease has become influence Chinese residents improved health/The development of economy and society in major public health problem and social problem.The prevention and control of chronic diseases need comprehensive measures,Need more the social from all walks of life/National common participation and efforts.

　　近年来，很多跨国药企将研发和生产重心转移到中国。在揭牌仪式上，诺和诺德负责人称，将加强中国疑难病学研究的支持，并捐助100万美元建立血友病研究基金，基金由中国医学科学院、上海转化学研究中心、中国科学院的专家组成的管理委员会进行管理。

In recent years,Many multinational pharmacy enterprises will research and development and production of focus to China.In the inaugural ceremony,Novo nordisk responsible person,China will strengthen difficult epidemiological studies support,And donate $1 million to establish hemophilia research fund,Fund by the Chinese academy of medical sciences/Shanghai transformation science research center/The Chinese academy of sciences of the management committee of experts carry on the management.

　　陈竺说，目前，中国约有血友病患者10万余人，为加强防治工作，中国初步建立了病例信息登记管理系统，加大临床规范治疗的培训，积极做好凝血因子、凝血酶原复合物的研发、生产和供应、协调等工作，努力提高单采血浆采集量，引导企业提高血浆利用率，并将其纳入医保报销范围，不断提高保障水平。

Outlines said,At present,China has an estimated hemophiliac of more than 100000 people,In order to strengthen the prevention and control,China set up the case information registration management system,Increase clinical standard treatment of training,Completes the clotting factor/Prothrombin complex development/Production and supply/Coordination work,To improve the single plasma collection capacity,Guide enterprises to improve utilization rate of plasma,And shall incorporate it into the scope of medical insurance to submit an expense account,Constantly improve the level of security.

　　“我们倡导具有先进技术和成熟管理水平的企业和机构与中国展开合作，卫生部和相关地方政府将在项目、政策、人才等方面给予全方位支持。”陈竺说。(完)

"We advocate has advanced technology and mature management level of enterprises and institutions and Chinese collaboration,The ministry of health and the relevant local government will in the project/policy/The respect such as the talent to give full support."Outlines said.(finish)